# PEACE V: Salvage Treatment of OligoRecurrent Nodal Prostate Cancer Metastases

> **NCT03569241** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **University Hospital, Ghent** · enrollment: 196 (actual)

## Conditions studied

- Prostate Cancer
- Prostate Cancer Metastatic
- Metastatic Cancer
- Oligometastatic Cancer

## Interventions

- **RADIATION:** whole pelvic radiotherapy
- **RADIATION:** metastasis-directed treatment
- **PROCEDURE:** salvage Lymph Node Dissection
- **DRUG:** androgen deprivation therapy

## Key facts

- **NCT ID:** NCT03569241
- **Lead sponsor:** University Hospital, Ghent
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-04-27
- **Primary completion:** 2023-04-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 196 (ACTUAL)
- **Last updated:** 2024-12-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03569241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03569241, "PEACE V: Salvage Treatment of OligoRecurrent Nodal Prostate Cancer Metastases". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03569241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*